Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 18

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 18
---
 Development; Kenny Ablordeppey, Director of Assay Development; Jacob Goldman, Data
Scientist; and Sydney Finkelstein, Medical Director.

In addition, concurrently
with the execution of the Merger Agreement, DiamiR, DiamiR LLC, and ATL entered into an intellectual property license agreement pursuant
to which DiamiR and DiamiR LLC shall license on a non-exclusive basis their respective intellectual properties to the Company in exchange
for upfront and periodic payments and royalties until the earlier of the closing of the Merger or December 31, 2025.

Upon closing of the DiamiR
Merger, Aptorum and certain stockholders of DiamiR, who collectively own 84.9% of DiamiR’s outstanding shares, will sign a stockholders
agreement (“Stockholders Agreement”), which will be effective until the earlier of (i) twelve (12) months following
the date thereof and (ii) the date on which the stockholders of DiamiR beneficially own, in the aggregate, a number of shares of
common stock of the Combined Company equal to at least 25% of the then outstanding shares of the Combined Company (such beneficial ownership,
the “DiamiR Stockholders Beneficial Ownership”; such period, the “Appointment Period”). The parties agree that,
during the Appointment Period, they will take all necessary actions to cause the number of directors at the Board of the Combined Company
to be fixed at five (5). In addition, Kira S. Sheinerman, the co-founder and a stockholder of DiamiR, and her affiliates (“DiamiR
Primary Stockholder Parties”) will have the right to appoint two (2) designees (each designee, the “Primary Stockholder
Designee”, collectively, the “Primary Stockholder Designees”) for nomination and election to the Board of Combined Company,
and at least one (1) designee shall satisfy the independence requirements of Rule 5605(c)(2)(A) of the Nasdaq listing rules,
provided that the DiamiR Stockholders Beneficial Ownership is not less than 36%, and the DiamiR Primary Stockholder Parties will have
the right to appoint one (1) director nominee to the Board of Combined Company, provided that the DiamiR Stockholders Beneficial
Ownership is no less than 25%.

For the election of directors
of the Combined Company: (1) each stockholder of DiamiR, who is a party